PICO

296 results

Prognostic Role of Low-Skeletal Muscle Mass on Staging Computed Tomography in Metastasized Colorectal Cancer: A Systematic Review and Meta-Analysis.

Meyer HJ, Strobel A, Wienke A, Surov A - Clinical colorectal cancer, July 07, 2022 7 citations

metastasized colorectal cancer patients

I/C

low-skeletal muscle mass (LSMM), overall survival (OS)

influence on OS

Combining tumour response and progression free survival as surrogate endpoints for overall survival in advanced colorectal cancer.

Elia EG, Städler N, Ciani O, Taylor RS, Bujkiewicz S - Cancer epidemiology, January 09, 2020 4 citations

advanced colorectal cancer patients

I/C

pharmacological therapies, including systemic chemotherapies, anti-epidermal growth factor receptor therapies and anti-angiogenic agents, treatment effects on surrogate endpoints (TR, PFS) and final outcome (OS)

overall survival (OS)

Surrogate endpoints for overall survival in randomized clinical trials testing immune checkpoint inhibitors: a systematic review and meta-analysis.

Sala I, Pagan E, Pala L, Oriecuia C, Musca M, Specchia C, De Pas T, Cortes J, Giaccone G, Postow M, Gelber RD, Bagnardi V, Conforti F - Frontiers in immunology, February 13, 2024 1 citations

advanced solid tumors

I/C

immune-checkpoint inhibitors (ICIs), PFS and modified-PFS (mPFS) for OS

overall survival (OS)

Long Non-Coding RNA FOXD2-AS1 Serves as a Potential Prognostic Biomarker for Patients With Cancer: A Meta-Analysis and Database Testing.

Duan F, Li H, Liu W, Zhao J, Yang Z, Zhang J - The American journal of the medical sciences, July 26, 2021 1 citations

2,177 patients with OS and 477 patients with DFS/PFS data

I/C

FOXD2-AS1 expression, high expression of FOXD2-AS1 vs. low expression

poor OS, poor DFS, poor PFS

Surgery for liver metastases from primary breast cancer: A reconstructed individual patient data meta-analysis.

Masuda Y, Yeo MHX, Syn NL, Goh BKP, Koh YX - European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, November 24, 2023 2 citations

Breast Cancer Liver Metastases (BCLM)

I/C

Surgical and Non-Surgical Treatment, Overall Survival (OS)

Superior OS Outcomes

Prognostic and clinicopathological significance of systemic inflammation response index in patients with hepatocellular carcinoma: a systematic review and meta-analysis.

Zhang S, Tang Z - Frontiers in immunology, March 12, 2024 0 citations

patients with hepatocellular carcinoma (HCC)

I/C

systemic inflammation response index (SIRI), overall survival (OS) and progression-free survival (PFS)

dismal OS and inferior PFS

Local recurrence and survival after treatment of oral squamous cell carcinoma of the maxilla: A systematic review and meta-analysis.

Slieker FJB, Rombout DAA, de Bree R, Van Cann EM - Oral surgery, oral medicine, oral pathology and oral radiology, February 16, 2022 3 citations

Patients with oral squamous cell carcinoma involving the maxilla (MSCC)

I/C

Local recurrence (LR), overall survival (OS), and associated risk factors of MSCC, Surgery only vs. surgery with (neo)adjuvant treatment

5-year LR rate, 5-year OS rate, Odds ratio (OR)

Overall Survival After Systemic Treatment in High-volume Versus Low-volume Metastatic Hormone-sensitive Prostate Cancer: Systematic Review and Network Meta-analysis.

Wenzel M, Würnschimmel C, Nocera L, Collà Ruvolo C, Tian Z, Shariat SF, Saad F, Briganti A, Tilki D, Graefen M, Kluth LA, Roos FC, Mandel P, Chun FKH, Karakiewicz PI - European urology focus, April 16, 2021 34 citations

abiraterone, enzalutamide, apalutamide, docetaxel

I/C

combination therapy, hormonal treatments, chemotherapy, abiraterone vs. docetaxel, enzalutamide vs. docetaxel

overall survival (OS), median OS duration

Laparoscopic versus open transhiatal approach for adenocarcinoma of the esophagogastric junction: A systematic review and meta-analysis.

Chen XD, He FQ, Liao MS, Chen M - European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, December 04, 2020 3 citations

patients with adenocarcinoma of the esophagogastric junction (AEG)

I/C

laparoscopic transhiatal approach (LTH), open transhiatal approach (OTH)

operation time, blood loss, lymph nodes harvested, time to ambulation, time to first flatus, postoperative hospital stay, mortality, total major complications, 2-year overall survival (OS) rate, 5-year OS rate, OS (univariable and multivariable hazard ratios)

Sarcopenia and prognosis of advanced cancer patients receiving immune checkpoint inhibitors: A comprehensive systematic review and meta-analysis.

Deng HY, Chen ZJ, Qiu XM, Zhu DX, Tang XJ, Zhou Q - Nutrition (Burbank, Los Angeles County, Calif.), June 25, 2021 29 citations

patients with advanced cancer

I/C

receiving immune checkpoint inhibitors (ICIs), sarcopenia vs. no sarcopenia

response rate, 1-y progression-free survival (PFS) rate, 1-y overall survival (OS) rate, hazard ratios (HRs) of PFS and OS

Papers